Monitor redemption levels ahead of the December 2 vote; higher redemptions increase dilution for remaining shareholders and reduce cash available to the combined company. The Nasdaq listing condition may be waived, which would remove a key closing condition and increase execution risk.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $10.25entry
- T+1 · 6d ago +2.19%α +0.87% · $10.47
- T+4 · todayOpen
- T+5 · in 5h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
JATT II Acquisition Corp. is holding a shareholder vote on December 2, 2026 to approve its business combination with Talawar Tx Inc., a biopharmaceutical company. Under the deal, Talawar stockholders will receive approximately 12.5 million shares of the combined company (valued at $120 million at $10/share), JATT public shareholders will receive one share per JATT share, and a $225 million PIPE at $10/share will close concurrently. The JATT board unanimously recommends approval (with Dr. Sidhu recused due to conflicts as Talawar's majority stockholder and Khanda's CEO), and Houlihan Capital opined the consideration is fair to JATT's unaffiliated shareholders.
Key Financial Metrics
Key Facts
- JATT shareholders vote on December 2, 2026 to approve merger with Talawar Tx Inc.
- Talawar equity valued at $120 million, paid in ~12.5 million shares of combined company at $10/share
- $225 million PIPE at $10/share (22.5 million shares) from institutional investors including Access affiliates
- JATT public shareholders get 1 share per share; redemption price ~$10.19/share as of Nov 3, 2026
- Minimum Cash Condition requires at least $125 million available cash after redemptions and expenses
- Board unanimously recommends FOR (Dr. Sidhu recused); Houlihan Capital fairness opinion obtained
- Sponsor (23.1% of shares) committed to vote FOR and waive redemption; 150,000 founder shares forfeited
- Post-closing company to list on Nasdaq under proposed ticker TLWR; listing condition may be waived
- Dr. Sidhu is JATT CEO, Talawar majority stockholder, and Khanda CEO/ founder creating conflicts
- Khanda and Access will own 22.3% and 14.7% respectively of post-closing company (no redemption scenario)
Financial Impact
Talawar equity value $120 million; PIPE $225 million; trust account ~$61.2 million as of Nov 3, 2026
Risk Factors
- High redemptions could reduce available cash below the $125 million Minimum Cash Condition threshold
- Nasdaq listing condition may be waived, leaving post-closing stock unlisted on a national exchange
- Conflicts of interest from overlapping board/ownership among JATT, Talawar, Khanda, and Access
- Merger may be taxable to JATT public shareholders; legal counsel unable to opine on tax-free treatment
Market Snapshot
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFM14A Filing (Primary) | 0001193125-26-453744 |
| Document: talawar__defm14a.htm | 0001193125-26-453744 |
Track record
10 reports on JATT
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $10.20 Now $10.20 −0.00% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $10.38 Now $10.20 −1.69% settles Dec 15
- Nov 9, 20267d ago DEFM14A Neutral 5/10 Viewing Entry $10.25 Now $10.20 −0.49% settles Dec 9
- Sep 18, 20268w ago SC 13D/A Neutral 2/10 Entry $12.24 to $10.25 Now $10.20 −16.67% ▼ −16.26% −15.35% vs SPY
- Sep 15, 20268w ago SC 13D Neutral 3/10 Entry $12.03 to $10.37 Now $10.20 −15.21% ▼ −13.80% −15.86% vs SPY
- Aug 27, 202611w ago Press Release Neutral 4/10 Entry $12.01 to $11.42 Now $10.20 −15.07% ▼ −4.91% −4.40% vs SPY
- Aug 25, 202611w ago Press Release Neutral 4/10 Entry $12.01 to $11.42 Now $10.20 −15.07% ▼ −4.91% −5.14% vs SPY
- Apr 24, 202629w ago 8-K Neutral 5/10 Entry $10.94 to $10.90 Now $10.20 −6.76% ▼ −0.37% −5.32% vs SPY
- Apr 20, 202630w ago Press Release Neutral 5/10 Entry $10.20 to $10.95 Now $10.20 −0.00% ▲ +7.35% +2.44% vs SPY
- Apr 16, 202630w ago Press Release Neutral 5/10 Entry $10.50 to $10.55 Now $10.20 −2.86% ▲ +0.48% −4.89% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers